Dice CEO: Energy, T...
Health Care: Drugs
DUSA Pharmaceuticals Inc. (DUSA: NASDAQ)
$4.91 -0.25 | -4.84%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 4.91 |
| 52 Week High | 6.62 |
| 52 Week Low | 3.25 |
| Avg. Daily Vol. (Mil) | 0.20 |
| Beta (3 year) | 1.45 |
| Share Related Items | |
| Mkt Cap (Mil) | 122.42 |
| Shares Out (Mil) | 24.93 |
| Float (Mil) | 24.10 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.80 |
| Current Ratio | 6.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 16.90 |
| Price/Sales | 2.57 |
| Price/Book | 4.35 |
| Price/Cash Flow | 15.10 |
| Per Share Data | |
| Earnings | 0.29 |
| Sales | 1.91 |
| Book Value | 1.13 |
| Cash Flow | 0.32 |
| Business Summary | |
|---|---|
| DUSA Pharmaceuticals, Inc. is a vertically integrated dermatology company that is developing and marketing pharmaceuticals for the treatment of skin conditions such as actinic keratoses and acne. | |
| General Information | |
| 25 Upton Drive
Wilmington, MA 01887 |
|
| www.dusapharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 96 | |
| CEO: Robert Doman | |
| Short Interest | |
| Current Month (Mil) | 1.47 |
| Previous Month (Mil) | 1.41 |
| Short Interest Ratio (Days) | 9.70 |
| Management Effectiveness | |
| Return on Equity | 26.90 |
| Return on Assets | 19.50 |
| Return on Investments | 26.90 |
| Profitability | |
| Gross Margin | 85.90 |
| EBIT Margin | 14.80 |
| Profit Margin | 15.90 |
Portfolios with DUSA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorTop-Rated Biotechnology Stocks
- UserThatBobGuy Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorTop 10 Insider Purchases: J...
- Userjoshuparks Portfolio 1
- Uservladys buttom fishing
- Userbill 3
- UserHeld's
Latest DUSA Headlines from TheStreet
- 8 Stocks Under $10 Ripping Higher 05.03.12 | 01:05 pm
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 11.14.11 | 06:11 am
- DUSA Pharmaceuticals Inc. Stock Downgraded (DUSA) 07.28.11 | 07:07 am
- DUSA Stock Hits New 52-Week High (DUSA) 05.25.11 | 10:05 am
- DUSA Stock Soars (DUSA) 05.05.11 | 10:05 am
- DUSA Pharmaceuticals Inc. Stock Upgraded (DUSA) 03.04.11 | 05:03 pm
- DUSA Stock Soars Higher (DUSA) 03.03.11 | 10:03 am
- Cautious Bull
03.08.10 | 11:03 am - The Pisani Paradox 09.28.09 | 11:09 am
- Wednesday's Health Winners & Losers 10.03.07 | 03:10 pm
Press Releases for DUSA
- DUSA Pharmaceuticals, Inc.® To Host First Quarter 2011 Corporate Highlights And Financial Results Webcast And Conference Call - Business Wire 04.28.11 | 08:04 am
- A Patient Receiving Levulan Photodynamic Therapy. (Photo: Business Wire) - Business Wire 03.03.11 | 06:03 am
- DUSA Pharmaceuticals, Inc.® To Host Fourth Quarter And Full Year 2010 Corporate Highlights And Financial Results Conference Call - Business Wire 02.25.11 | 06:02 am
- DUSA Pharmaceuticals To Present At The 4th Annual Maxim Group Growth Conference - PR Newswire 11.11.10 | 08:11 am
- DUSA Pharmaceuticals Named To Deloitte's 2010 Technology Fast 500 List Of Fastest Growing Companies In North America - PR Newswire 10.26.10 | 03:10 pm
- DUSA Pharmaceuticals To Present At The Rodman & Renshaw 12th Annual Healthcare Conference - PR Newswire 09.07.10 | 08:09 am
- DUSA Pharmaceuticals Receives Response From FDA On Orphan Drug Designation Status - PR Newswire 08.06.10 | 12:08 pm
- DUSA Pharmaceuticals Reports U.S. Patent Office Upholds Key Photodynamic Therapy Patent - PR Newswire 06.24.10 | 06:06 am
- DUSA Pharmaceuticals Announces Slate Of Nominees For Election To The Board Of Directors - PR Newswire 05.13.10 | 12:05 pm
- DUSA Pharmaceuticals Reports Notice Of Allowance For Key PDT Device Patent - PR Newswire 05.07.10 | 06:05 am
Partner Headlines for DUSA
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 03.30.12 | 09:03 am
- DUSA Pharmaceuticals Is A Small Gem - Seeking Alpha 12.23.11 | 02:12 pm
- 20 Smart Money Stock Picks Trading Under $5 - Seeking Alpha 11.03.11 | 07:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.01.11 | 09:07 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 03.07.11 | 09:03 am
- Morning Market Movers (GTEC, ASGR, LSBK, DUSA) - Benzinga 03.03.11 | 09:03 am
- UPDATE 1-DUSA to end skin drug deal with Stiefel Laboratories - Reuters 10.06.10 | 08:10 am
- UPDATE 1-DUSA to stop cancer trial as FDA denies orphan status - Reuters 08.06.10 | 02:08 pm
